The price of Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) closed at $2.49 in the last session, up 1.63% from day before closing price of $2.45. On the day, 181021 shares were traded.
Ratios:
We take a closer look at AVAH’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 10.90 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 28.93. For the most recent quarter (mrq), Quick Ratio is recorded 0.89 and its Current Ratio is at 0.89.
On November 30, 2023, UBS started tracking the stock assigning a Sell rating and target price of $1.50.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 06 ’23 when GANZI VICTOR F bought 200 shares for $1.23 per share. The transaction valued at 246 led to the insider holds 236,617 shares of the business.
GANZI VICTOR F bought 3,200 shares of AVAH for $3,776 on Jun 01 ’23. The Director now owns 236,417 shares after completing the transaction at $1.18 per share. On May 31 ’23, another insider, GANZI VICTOR F, who serves as the Director of the company, bought 11,850 shares for $1.15 each. As a result, the insider paid 13,616 and bolstered with 233,217 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AVAH now has a Market Capitalization of 465.56M and an Enterprise Value of 1.77B. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.25. Its current Enterprise Value per Revenue stands at 0.93 whereas that against EBITDA is 45.08.
Stock Price History:
The Beta on a monthly basis for AVAH is 2.03, which has changed by 133.33% over the last 52 weeks, in comparison to a change of 27.86% over the same period for the S&P500. Over the past 52 weeks, AVAH has reached a high of $3.00, while it has fallen to a 52-week low of $0.85. The 50-Day Moving Average of the stock is 2.3911, while the 200-Day Moving Average is calculated to be 1.9236.
Shares Statistics:
According to the various share statistics, AVAH traded on average about 93.09K shares per day over the past 3-months and 112.02k shares per day over the past 10 days. A total of 190.73M shares are outstanding, with a floating share count of 52.96M. Insiders hold about 72.47% of the company’s shares, while institutions hold 20.25% stake in the company. Shares short for AVAH as of Mar 15, 2024 were 1.07M with a Short Ratio of 11.49, compared to 1.28M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.56% and a Short% of Float of 1.96%.
Earnings Estimates
The company has 8 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.04 for the current quarter, with a high estimate of -$0.03 and a low estimate of -$0.06, while EPS last year was -$0.05. The consensus estimate for the next quarter is -$0.02, with high estimates of $0.01 and low estimates of -$0.03.
Analysts are recommending an EPS of between -$0.06 and -$0.1 for the fiscal current year, implying an average EPS of -$0.08. EPS for the following year is -$0.02, with 8 analysts recommending between $0.02 and -$0.06.
Revenue Estimates
According to 8 analysts, the current quarter’s revenue is expected to be $485.63M. It ranges from a high estimate of $490.06M to a low estimate of $481M. As of the current estimate, Aveanna Healthcare Holdings Inc’s year-ago sales were $466.41M, an estimated increase of 4.10% from the year-ago figure. For the next quarter, 8 analysts are estimating revenue of $491.55M, an increase of 4.20% over than the figure of $4.10% in the same quarter last year. There is a high estimate of $494.79M for the next quarter, whereas the lowest estimate is $488.2M.
A total of 8 analysts have provided revenue estimates for AVAH’s current fiscal year. The highest revenue estimate was $1.98B, while the lowest revenue estimate was $1.97B, resulting in an average revenue estimate of $1.98B. In the same quarter a year ago, actual revenue was $1.9B, up 4.20% from the average estimate. Based on 8 analysts’ estimates, the company’s revenue will be $2.08B in the next fiscal year. The high estimate is $2.09B and the low estimate is $2.06B. The average revenue growth estimate for next year is up 5.10% from the average revenue estimate for this year.
